High Homocysteine Despite Normal B12 and Folate: What Next?

In our knowledge-base entry on homocysteine, we describe it as an amino acid whose metabolism depends on three vitamins — B12, folate, and B6 — working through two parallel pathways. Most guides, and most primary-care conversations, stop there: elevated homocysteine means check B12 and folate, supplement, done. In many cases that genuinely solves the problem. But what happens when B12 and folate both come back normal and homocysteine stays elevated anyway?

That isn't a rare anomaly calling for a repeat test at another lab. It's a sign that whatever is driving the elevated homocysteine sits somewhere else in the metabolic cycle than the part that gets checked first. This article assumes you already know what homocysteine is and roughly how its metabolism works — here we focus exclusively on this narrower situation: normal B12 and folate, homocysteine still high.

Homocysteine, a byproduct of methyl-group transfer from methionine, can be cleared from the blood through two entirely different routes. The first is remethylation back to methionine — this pathway needs vitamin B12 as a cofactor for the enzyme methionine synthase and folate as the methyl donor. It's the pathway checked first because it's easiest to test and explains the majority of cases in the general population.

The second route is transsulfuration — an irreversible conversion of homocysteine to cysteine, catalyzed by the enzyme cystathionine beta-synthase, which requires vitamin B6 (in its active form, pyridoxal-5-phosphate) as a cofactor. This pathway is entirely independent of B12 and folate. If B12 and folate are normal but B6 is deficient, all the homocysteine that would normally flow into transsulfuration gets backed up and accumulates in the blood — regardless of how well the remethylation pathway is working.

A second layer of nuance: even once B6 gets tested, interpreting it isn't as straightforward as with B12. The standard test measures pyridoxal-5-phosphate in the blood, but this marker is sensitive to acute inflammation — during an active inflammatory response, circulating PLP drops regardless of actual tissue stores, which can lead to a falsely low reading in someone who currently has an infection or an unrelated active inflammatory process.

On top of that, the effect of B6 deficiency on homocysteine isn't simply linear — in most people with moderately low B6, fasting homocysteine stays within the normal range, because the body keeps some reserve capacity in the transsulfuration pathway. The gap shows up more clearly after a so-called methionine loading test, where an oral methionine dose is given and the rise in homocysteine is measured hours later — this method, rarely used in routine practice, demonstrates impaired transsulfuration far more reliably than a single fasting measurement, which could otherwise miss it entirely.

If B6 also comes back normal, it's worth looking beyond vitamins altogether. Homocysteine is partly metabolized and cleared by the kidneys — even a moderate decline in kidney filtration, before creatinine rises noticeably, is well documented to raise blood homocysteine. That's why it's worth checking eGFR and creatinine at this point, covered in more depth in our entry on creatinine and eGFR — declining kidney filtration is one of the most commonly overlooked causes of elevated homocysteine in older adults, where the result can look unexplained until kidney function is factored in.

Hypothyroidism is another lead, less often connected to homocysteine than it should be. Thyroid hormones influence the activity of enzymes in the methionine cycle, and in people with untreated hypothyroidism, homocysteine can be elevated even with a perfectly adequate vitamin supply — once TSH and free T4 are corrected, homocysteine often normalizes on its own in many of these cases, without any additional supplementation. If thyroid function hasn't been checked recently, it's a natural next step — especially in women over 40, the group most often affected by undiagnosed hypothyroidism.

Finally, a handful of medications raise homocysteine independently of vitamin status: methotrexate (a folate antagonist at the cellular level, not just in serum), older-generation anticonvulsants, cholestyramine, and — interestingly — metformin itself, which in some patients subtly reduces B12 absorption enough that the standard blood B12 result still looks normal, even though a functional deficiency is already developing at the tissue level. We cover this phenomenon in more detail in our article on metformin and vitamin B12.

In practice, this means genetic testing for MTHFR makes the most sense as part of a broader cardiovascular risk assessment in families with a history of clotting disorders or very early coronary disease, rather than as a first step for everyone with borderline-elevated homocysteine and normal vitamins. Knowing the genetic variant doesn't itself change treatment — the approach stays the same: ensure a genuinely adequate, not just borderline, folate and B12 supply, regardless of the genetic test result.

Elevated homocysteine alongside normal B12 and folate can feel frustrating, since it seems to contradict the simple, often-repeated diagnostic script. In reality, it's simply a signal to move to a second, narrower layer of workup — less obvious, but still well documented in the literature. Vitamin B6, kidney function, and thyroid function are three leads that genuinely explain most of these cases, and none of them require exotic testing — standard tests available at any lab are enough.